KRAS Inhibitor Market Size, Share & Trends Analysis Report By Type (KRAS G12C Inhibitors, KRAS G12D Inhibitors, Others), By Drug (Sotorasib, Adagrasib, Fulzerasib, Garsorasib), By Disease Indication (Non-small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer, Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Drug Stores & Retail Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. KRAS Inhibitor Market Size Analysis
    1. Introduction
    2. KRAS Inhibitor Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. KRAS G12C Inhibitors
      2. KRAS G12D Inhibitors
      3. Others
    3. KRAS Inhibitor Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Sotorasib
      2. Adagrasib
      3. Fulzerasib
      4. Garsorasib
    4. KRAS Inhibitor Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Non-small Cell Lung Cancer
      2. Colorectal Cancer
      3. Pancreatic Cancer
      4. Biliary Tract Cancer
      5. Others
    5. KRAS Inhibitor Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Specialty Pharmacies
      3. Drug Stores & Retail Pharmacies
  7. North America KRAS Inhibitor Market Size Analysis
    1. Introduction
    2. KRAS Inhibitor Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. KRAS G12C Inhibitors
      2. KRAS G12D Inhibitors
      3. Others
    3. KRAS Inhibitor Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Sotorasib
      2. Adagrasib
      3. Fulzerasib
      4. Garsorasib
    4. KRAS Inhibitor Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Non-small Cell Lung Cancer
      2. Colorectal Cancer
      3. Pancreatic Cancer
      4. Biliary Tract Cancer
      5. Others
    5. KRAS Inhibitor Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Specialty Pharmacies
      3. Drug Stores & Retail Pharmacies
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
  8. Europe KRAS Inhibitor Market Size Analysis
    1. Introduction
    2. KRAS Inhibitor Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. KRAS G12C Inhibitors
      2. KRAS G12D Inhibitors
      3. Others
    3. KRAS Inhibitor Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Sotorasib
      2. Adagrasib
      3. Fulzerasib
      4. Garsorasib
    4. KRAS Inhibitor Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Non-small Cell Lung Cancer
      2. Colorectal Cancer
      3. Pancreatic Cancer
      4. Biliary Tract Cancer
      5. Others
    5. KRAS Inhibitor Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Specialty Pharmacies
      3. Drug Stores & Retail Pharmacies
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
  9. APAC KRAS Inhibitor Market Size Analysis
    1. Introduction
    2. KRAS Inhibitor Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. KRAS G12C Inhibitors
      2. KRAS G12D Inhibitors
      3. Others
    3. KRAS Inhibitor Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Sotorasib
      2. Adagrasib
      3. Fulzerasib
      4. Garsorasib
    4. KRAS Inhibitor Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Non-small Cell Lung Cancer
      2. Colorectal Cancer
      3. Pancreatic Cancer
      4. Biliary Tract Cancer
      5. Others
    5. KRAS Inhibitor Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Specialty Pharmacies
      3. Drug Stores & Retail Pharmacies
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
  10. Middle East and Africa KRAS Inhibitor Market Size Analysis
    1. Introduction
    2. KRAS Inhibitor Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. KRAS G12C Inhibitors
      2. KRAS G12D Inhibitors
      3. Others
    3. KRAS Inhibitor Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Sotorasib
      2. Adagrasib
      3. Fulzerasib
      4. Garsorasib
    4. KRAS Inhibitor Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Non-small Cell Lung Cancer
      2. Colorectal Cancer
      3. Pancreatic Cancer
      4. Biliary Tract Cancer
      5. Others
    5. KRAS Inhibitor Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Specialty Pharmacies
      3. Drug Stores & Retail Pharmacies
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
  11. LATAM KRAS Inhibitor Market Size Analysis
    1. Introduction
    2. KRAS Inhibitor Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. KRAS G12C Inhibitors
      2. KRAS G12D Inhibitors
      3. Others
    3. KRAS Inhibitor Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Sotorasib
      2. Adagrasib
      3. Fulzerasib
      4. Garsorasib
    4. KRAS Inhibitor Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Non-small Cell Lung Cancer
      2. Colorectal Cancer
      3. Pancreatic Cancer
      4. Biliary Tract Cancer
      5. Others
    5. KRAS Inhibitor Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Specialty Pharmacies
      3. Drug Stores & Retail Pharmacies
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. KRAS G12C Inhibitors
        2. KRAS G12D Inhibitors
        3. Others
      3. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Sotorasib
        2. Adagrasib
        3. Fulzerasib
        4. Garsorasib
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Non-small Cell Lung Cancer
        2. Colorectal Cancer
        3. Pancreatic Cancer
        4. Biliary Tract Cancer
        5. Others
      5. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Specialty Pharmacies
        3. Drug Stores & Retail Pharmacies
  12. Competitive Landscape
    1. KRAS Inhibitor Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Amgen Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bristol Myers Squibb (US)
    3. Innovent (China)
    4. InventisBio Co. Ltd. (China)
    5. Lilly (US)
    6. Hoffmann-La Roche Ltd. (Switzerland)
    7. Novartis AG (Switzerland)
    8. Merck & Co. Inc. (US)
    9. Astellas Pharma (Japan)
    10. Jacobio Pharmaceuticals (China)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global KRAS Inhibitor Market Size and Forecast By Regions - 2022-2034 (USD Million)

Table 2: Global KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 3: Global KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 4: Global KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 5: Global KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 6: North America KRAS Inhibitor Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 7: North America KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 8: North America KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 9: North America KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 10: North America KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 11: U.S. KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 12: U.S. KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 13: U.S. KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 14: U.S. KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 15: Canada KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 16: Canada KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 17: Canada KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 18: Canada KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 19: Europe KRAS Inhibitor Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 20: Europe KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 21: Europe KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 22: Europe KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 23: Europe KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 24: U.K. KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 25: U.K. KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 26: U.K. KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 27: U.K. KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 28: Germany KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 29: Germany KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 30: Germany KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 31: Germany KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 32: France KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 33: France KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 34: France KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 35: France KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 36: Spain KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 37: Spain KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 38: Spain KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 39: Spain KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 40: Italy KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 41: Italy KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 42: Italy KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 43: Italy KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 44: Russia KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 45: Russia KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 46: Russia KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 47: Russia KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 48: Nordic KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 49: Nordic KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 50: Nordic KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 51: Nordic KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 52: Benelux KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 53: Benelux KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 54: Benelux KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 55: Benelux KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 56: Rest of Europe KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 57: Rest of Europe KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 58: Rest of Europe KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 59: Rest of Europe KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 60: APAC KRAS Inhibitor Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 61: APAC KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 62: APAC KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 63: APAC KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 64: APAC KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 65: China KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 66: China KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 67: China KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 68: China KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 69: Korea KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 70: Korea KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 71: Korea KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 72: Korea KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 73: Japan KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 74: Japan KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 75: Japan KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 76: Japan KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 77: India KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 78: India KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 79: India KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 80: India KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 81: Australia KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 82: Australia KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 83: Australia KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 84: Australia KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 85: Taiwan KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 86: Taiwan KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 87: Taiwan KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 88: Taiwan KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 89: South East Asia KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 90: South East Asia KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 91: South East Asia KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 92: South East Asia KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 93: Rest of Asia-Pacific KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 94: Rest of Asia-Pacific KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 95: Rest of Asia-Pacific KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 96: Rest of Asia-Pacific KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 97: Middle East and Africa KRAS Inhibitor Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 98: Middle East and Africa KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 99: Middle East and Africa KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 100: Middle East and Africa KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 101: Middle East and Africa KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 102: UAE KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 103: UAE KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 104: UAE KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 105: UAE KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 106: Turkey KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 107: Turkey KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 108: Turkey KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 109: Turkey KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 110: Saudi Arabia KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 111: Saudi Arabia KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 112: Saudi Arabia KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 113: Saudi Arabia KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 114: South Africa KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 115: South Africa KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 116: South Africa KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 117: South Africa KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 118: Egypt KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 119: Egypt KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 120: Egypt KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 121: Egypt KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 122: Nigeria KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 123: Nigeria KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 124: Nigeria KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 125: Nigeria KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 126: Rest of MEA KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 127: Rest of MEA KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 128: Rest of MEA KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 129: Rest of MEA KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 130: LATAM KRAS Inhibitor Market Size and Forecast By Country - 2022-2034 (USD Million)

Table 131: LATAM KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 132: LATAM KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 133: LATAM KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 134: LATAM KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 135: Brazil KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 136: Brazil KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 137: Brazil KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 138: Brazil KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 139: Mexico KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 140: Mexico KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 141: Mexico KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 142: Mexico KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 143: Argentina KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 144: Argentina KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 145: Argentina KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 146: Argentina KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 147: Chile KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 148: Chile KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 149: Chile KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 150: Chile KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 151: Colombia KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 152: Colombia KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 153: Colombia KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 154: Colombia KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

Table 155: Rest of LATAM KRAS Inhibitor Market Size and Forecast By Type - 2022-2034 (USD Million)

Table 156: Rest of LATAM KRAS Inhibitor Market Size and Forecast By Drug - 2022-2034 (USD Million)

Table 157: Rest of LATAM KRAS Inhibitor Market Size and Forecast By Disease Indication - 2022-2034 (USD Million)

Table 158: Rest of LATAM KRAS Inhibitor Market Size and Forecast By Distribution Channel - 2022-2034 (USD Million)

We are featured on: